World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Germany
2026
Award Badge
Medicine
Germany
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
149
Citations
96638
World Ranking
186
National Ranking
11

Medicine

D-Index
149
Citations
96613
World Ranking
1188
National Ranking
58

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Germany Leader Award
  • 2026 - Research.com Medicine in Germany Leader Award
  • 2025 - Research.com Biology and Biochemistry in Germany Leader Award
  • 2023 - Research.com Biology and Biochemistry in Germany Leader Award
  • 2022 - Research.com Biology and Biochemistry in Germany Leader Award
  • 2003 - Member of Academia Europaea
  • 1995 - Robert Koch Prize

Overview

Peter H. Krammer is a researcher affiliated with the German Cancer Research Center in Germany. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in subfields such as Immunology, Dermatology, Artificial Intelligence, Molecular Biology, and Pathology and Forensic Medicine.

The scientist's work covers several main topics, including:

  • Cutaneous lymphoproliferative disorders research
  • T-cell and Retrovirus Studies
  • Immune Response and Inflammation
  • S100 Proteins and Annexins
  • Lymphoma Diagnosis and Treatment
  • Fungal Infections and Studies
  • Nail Diseases and Treatments

The recent publications by Peter H. Krammer reflect a focus on cancer research, immune cell behavior, and related biomedical fields. Key papers include:

  • "Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study" (2023, Blood)
  • "Flow-cytometric Detection of Low-level Reactive Oxygen Species in Cell Lines and Primary Immune Cells" (2020, BIO-PROTOCOL)
  • "Molecular analysis of Annexin expression in cancer" (2022, BMC Cancer)
  • "Using Satellite Imagery to Improve Local Pollution Models for High-Voltage Transmission Lines and Insulators" (2022, Future Internet)
  • "Dimethyl fumarate (DMF) therapy in CTCL: results from a clinical phase II study" (2021, European Journal of Cancer)

Frequent publication venues for this researcher include:

  • European Journal of Cancer
  • Future Internet
  • Blood
  • BIO-PROTOCOL
  • BMC Cancer

Collaboration appears to be a significant element of their research, with frequent co-authors comprising Ladislav Hluchý, Marcel Kvassay, Ján Mojžiš, Jan P. Nicolay, and Miloš Očkay.

Peter H. Krammer has received recognition in the scientific community, including membership in Academia Europaea since 2003 and the Robert Koch Prize awarded in 1995.

Best Publications

  • Two CD95 (APO-1/Fas) signaling pathways

    Carsten Scaffidi;Simone Fulda;Anu Srinivasan;Claudia Friesen

  • FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

    Marta Muzio;Arul M. Chinnaiyan;Frank C. Kischkel;Karen O'Rourke

  • Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.

    Frank C. Kischkel;Stefan Hellbardt;Iris Behrmann;Matthias Germer

  • Monoclonal antibody-mediated tumor regression by induction of apoptosis

    Bernhard C. Trauth;Christiane Klas;Anke M.J. Peters;Siegfried Matzku

  • Death and anti-death: tumour resistance to apoptosis

    Frederik H. Igney;Peter H. Krammer

  • CD95's deadly mission in the immune system

    Peter H. Krammer

  • Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

    Jens Dhein;Henning Walczak;Caroline Bäumler;Klaus-Michael Debatin

  • Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

    Margot Thome;Pascal Schneider;Kay Hofmann;Helmut Fickenscher

  • FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

    Jan Paul Medema;Carsten Scaffidi;Frank C. Kischkel;Andrej Shevchenko

  • The CD95(APO-1/Fas) DISC and beyond

    M E Peter;P H Krammer

  • Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.

    Claudia Friesen;Ingrid Herr;Ingrid Herr;Peter H. Krammer;Klaus Michael Debatin;Klaus Michael Debatin

  • Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

    Susanne Strand;Walter J. Hofmann;Hubert Hug;Martina Müller

  • Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

    Michael O. Westendorp;Rainer Frank;Christina Ochsenbauer;Kirstin Stricker

  • p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs

    Martina Müller;Sylvia Wilder;Detlev Bannasch;David Israeli

  • The Role of c-FLIP in Modulation of CD95-induced Apoptosis *

    Carsten Scaffidi;Ingo Schmitz;Peter H. Krammer;Marcus E. Peter

  • FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis.

    Arul M. Chinnaiyan;Clifford G. Tepper;Michael F. Seldin;Karen O'Rourke

  • FADD/MORT1 and Caspase-8 Are Recruited to TRAIL Receptors 1 and 2 and Are Essential for Apoptosis Mediated by TRAIL Receptor 2

    Martin R Sprick;Markus A Weigand;Markus A Weigand;Eva Rieser;Charles T Rauch

  • Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

    Peter R. Galle;Walter J. Hofmann;Henning Walczak;Heinz Schaller

  • Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

    Martina Müller;Susanne Strand;Hubert Hug;Eva Maria Heinemann

  • Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.

    Andreas Strasser;Alan W. Harris;David C S Huang;Peter H. Krammer

Frequent Co-Authors

Min Li-Weber
Min Li-Weber German Cancer Research Center
Wolfgang Stremmel
Wolfgang Stremmel Heidelberg University
Klaus-Michael Debatin
Klaus-Michael Debatin University of Ulm
Henning Walczak
Henning Walczak University College London
Marcus E. Peter
Marcus E. Peter Northwestern University
Werner Falk
Werner Falk University of Regensburg
Andreas Krueger
Andreas Krueger Goethe University Frankfurt
Inna N. Lavrik
Inna N. Lavrik Otto-von-Guericke University Magdeburg
Gerry Melino
Gerry Melino University of Rome Tor Vergata
Daniela N. Männel
Daniela N. Männel University of Regensburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Biology and Biochemistry, a range of online degrees and career pathways exist in the healthcare field. A popular route is health information management, where professionals oversee medical data and patient records. Exploring the online health information management degree options can be a cost-effective way to enter this sector.

Another promising pathway is medical coding. Certified coding professionals analyze and code patient data for insurance and billing purposes. Understanding the differences between a certified coding specialist and other certifications can help you choose the best fit for your goals. When considering salary, many ask how much do medical coders make—expected salaries vary by location, certification, and experience.

The work environment in this sector is evolving, with remote and flexible positions now more common. If you’re weighing your options, you may wonder is medical coding a good job? Pros include job stability and career growth, while some may find aspects like repetitive tasks challenging. Ultimately, online degrees and certifications open up diverse opportunities for Biology and Biochemistry graduates in this rapidly growing industry.

Best Scientists Citing Peter H. Krammer

Trending Scientists